TY - JOUR
T1 - Association of preoperative biliary drainage technique with postoperative outcomes among patients with resectable hepatobiliary malignancy
AU - Hu, Q. Lina
AU - Liu, Jason B.
AU - Ellis, Ryan J.
AU - Liu, Jessica Y.
AU - Yang, Anthony D.
AU - D'Angelica, Michael I.
AU - Ko, Clifford Y.
AU - Merkow, Ryan P.
N1 - Funding Information:
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Drs. Q.L. Hu and J.Y. Liu receives salary support through a contract with Agency for Healthcare Research & Quality (HHSP233201500020I). Dr. R.J. Ellis is supported by a Postdoctoral Research Fellowship ( AHRQ5T32HS000078 ). Dr. R.P. Merkow is supported by the Agency for Healthcare Research and Quality ( K12HS026385 ) and an Institutional Research Grant from the American Cancer Society ( IRG-18-163-24 ).
Publisher Copyright:
© 2019 International Hepato-Pancreato-Biliary Association Inc.
PY - 2020/2
Y1 - 2020/2
N2 - Background: Endoscopic biliary stenting (EBS) and percutaneous transhepatic biliary drainage (PTBD) are two techniques used for preoperative biliary drainage prior to hepatobiliary resection. The objectives of this study were to determine predictors of the drainage technique selection and to evaluate the association between drainage technique and postoperative outcomes. Methods: Using ACS NSQIP data (2014–2017), patients who underwent preoperative biliary drainage prior to hepatobiliary resection for malignancy were identified. Separate multivariable-adjusted, propensity score (PS) adjusted, and PS matched logistic regression models were constructed to evaluate the association between drainage technique and postoperative outcomes. Results: Of 527 patients identified, 431 (81.8%) received EBS and 96 (18.2%) received PTBD. Patients who underwent PTBD had more preoperative co-morbidities, including higher ASA class, recent weight loss, and hypoalbuminemia (all p < 0.05). After multivariable adjustment, PTBD was significantly associated with 30-day DSM (OR 1.92, 95% CI 1.24–2.97, p = 0.004), overall SSI (OR 1.74, 95% CI 1.10–2.76, p = 0.019), and superficial SSI (OR 2.08, 95% CI 1.20–3.60, p = 0.010). These findings remained significant for both PS-adjusted and PS-matched models. Conclusion: Patients undergoing hepatobiliary resection selected for PTBD had significantly more preoperative co-morbidities and nutritional deficits. Compared to EBS, PTBD was associated with significantly higher odds of postoperative morbidity and mortality.
AB - Background: Endoscopic biliary stenting (EBS) and percutaneous transhepatic biliary drainage (PTBD) are two techniques used for preoperative biliary drainage prior to hepatobiliary resection. The objectives of this study were to determine predictors of the drainage technique selection and to evaluate the association between drainage technique and postoperative outcomes. Methods: Using ACS NSQIP data (2014–2017), patients who underwent preoperative biliary drainage prior to hepatobiliary resection for malignancy were identified. Separate multivariable-adjusted, propensity score (PS) adjusted, and PS matched logistic regression models were constructed to evaluate the association between drainage technique and postoperative outcomes. Results: Of 527 patients identified, 431 (81.8%) received EBS and 96 (18.2%) received PTBD. Patients who underwent PTBD had more preoperative co-morbidities, including higher ASA class, recent weight loss, and hypoalbuminemia (all p < 0.05). After multivariable adjustment, PTBD was significantly associated with 30-day DSM (OR 1.92, 95% CI 1.24–2.97, p = 0.004), overall SSI (OR 1.74, 95% CI 1.10–2.76, p = 0.019), and superficial SSI (OR 2.08, 95% CI 1.20–3.60, p = 0.010). These findings remained significant for both PS-adjusted and PS-matched models. Conclusion: Patients undergoing hepatobiliary resection selected for PTBD had significantly more preoperative co-morbidities and nutritional deficits. Compared to EBS, PTBD was associated with significantly higher odds of postoperative morbidity and mortality.
UR - http://www.scopus.com/inward/record.url?scp=85069636276&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85069636276&partnerID=8YFLogxK
U2 - 10.1016/j.hpb.2019.06.011
DO - 10.1016/j.hpb.2019.06.011
M3 - Article
C2 - 31350104
AN - SCOPUS:85069636276
VL - 22
SP - 249
EP - 257
JO - HPB
JF - HPB
SN - 1365-182X
IS - 2
ER -